Cargando…
Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19
The majority of COVID-19 survivors experience long-term neuropsychiatric symptoms such as fatigue, sleeping difficulties, depression and anxiety. We propose that neuroimmune cross-talk via inflammatory cytokines such as interleukin-6 (IL-6) could underpin these long-term COVID-19 symptoms. This hypo...
Autores principales: | Kappelmann, Nils, Dantzer, Robert, Khandaker, Golam M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172271/ https://www.ncbi.nlm.nih.gov/pubmed/34119855 http://dx.doi.org/10.1016/j.psyneuen.2021.105295 |
Ejemplares similares
-
Clinical phenotypes of depressed patients with evidence of inflammation and somatic symptoms
por: Foley, Éimear M., et al.
Publicado: (2021) -
Weight Change and Neuropsychiatric Symptoms in Alzheimer’s Disease and Frontotemporal Dementia: Associations with Cognitive Decline
por: Morrow, Christopher B., et al.
Publicado: (2023) -
Long-term persistence of symptoms of dyspnoea in COVID-19 patients
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022) -
Spectrum of neuropsychiatric manifestations in COVID-19
por: Nalleballe, Krishna, et al.
Publicado: (2020) -
Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts
por: Milaneschi, Yuri, et al.
Publicado: (2021)